Literature DB >> 1698529

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin.

H Sadek1, N Azli, J L Wendling, E Cvitkovic, M Rahal, G Mamelle, J C Guillaume, J P Armand, M F Avril.   

Abstract

The authors treated 14 patients with advanced squamous cell carcinoma (SCC) of the skin or lip with one to four cycles of combination chemotherapy consisting of cisplatin by bolus injection, and 5-fluorouracil (5-FU) and bleomycin by continuous 5-day infusion. Objective responses were seen in 11 of the 13 evaluable patients (84%). Four patients had a complete remission (30%) and seven patients, a partial remission (54%). Local control after definitive complementary radiation and/or surgical treatment was achieved in seven patients. Toxic side effects was acceptable; they consisted of nausea and vomiting in all patients, transient skin changes, hematologic (Grade 3/4) abnormalities in four patients, and pulmonary fibrosis in one elderly patient. These results show that this chemotherapy combination could play a role in reducing the tumor mass and in facilitating definitive treatment to obtain better functional and cosmetic results in advanced SCC of the skin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698529     DOI: 10.1002/1097-0142(19901015)66:8<1692::aid-cncr2820660807>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.

Authors:  Carol M Lewis; Bonnie S Glisson; Lei Feng; Fiona Wan; Ximing Tang; Ignacio I Wistuba; Adel K El-Naggar; David I Rosenthal; Mark S Chambers; Robert A Lustig; Randal S Weber
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

2.  Giant verrucous carcinoma of the lower extremity in women with dementia.

Authors:  Janina Jungmann; Thomas Vogt; Cornelia S L Müller
Journal:  BMJ Case Rep       Date:  2012-07-09

3.  An apparently untreatable ulcer of the face.

Authors:  Alessandro Borghi; Sergio Gianesini; Massimo Pedriali; Antonio Stefanelli; Giovanni Mangiola; Patrizia Dalla Caneva; Giovanni Lanza; Annarosa Virgili; Paolo Zamboni
Journal:  Int Wound J       Date:  2016-01-10       Impact factor: 3.315

4.  Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.

Authors:  Uwe Wollina; Gesina Hansel; Andreas Koch; Erich Köstler
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-24       Impact factor: 4.553

5.  Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma.

Authors:  Kenta Nakamura; Ryuhei Okuyama; Toshiaki Saida; Hisashi Uhara
Journal:  Int J Clin Oncol       Date:  2012-04-26       Impact factor: 3.402

Review 6.  Developments in the treatment of locally advanced and metastatic squamous cell carcinoma of the skin: a rising unmet need.

Authors:  Paul Palyca; Vadim P Koshenkov; Janice M Mehnert
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

7.  Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.

Authors:  Kathryn A Gold; Merrill S Kies; William N William; Faye M Johnson; J Jack Lee; Bonnie S Glisson
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

8.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

Review 9.  [Cutaneous squamous cell carcinoma: a review with consideration of special patient groups].

Authors:  U Hillen; M Ulrich; M Alter; J C Becker; R Gutzmer; U Leiter; A Lonsdorf; A Messerschmidt; C Ulrich
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

Review 10.  High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review.

Authors:  Flora Yan; Brittny N Tillman; Rajiv I Nijhawan; Divya Srivastava; David J Sher; Vladimir Avkshtol; Jade Homsi; Justin A Bishop; Erin M Wynings; Rebecca Lee; Larry L Myers; Andrew T Day
Journal:  Ann Surg Oncol       Date:  2021-06-30       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.